REG - GSK PLC - Block listing Interim Review

GSKAnnouncement

15/11/2022 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221115:nRSO4282Ga&default-theme=true

RNS Number : 4282G  GSK PLC  15 November 2022

  BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 15 November 2022

 

 Name of applicant:                                                                GSK plc
 Name of scheme:                                                                   GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
 Period of return:                        From:                                    1 May 2022          To:                 31 October 2022
 Balance of unallotted securities under scheme(s) from previous return:            44,219
 Plus:  The amount by which the block scheme(s) has been increased since the       0
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         0
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        44,219

 

 Name of applicant:                                                                GSK plc
 Name of scheme:                                                                   GlaxoSmithKline plc Share Save Plan 2012
 Period of return:                        From:                                    1 May 2022      To:             31 October 2022
 Balance of unallotted securities under scheme(s) from previous return:            1,373,495
 Plus:  The amount by which the block scheme(s) has been increased since the       0
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         251,620
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        1,121,875

 

 Name of contact:              Victoria Whyte
 Telephone number of contact:  020 8047 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRDELBFLFLXFBB